Uncategorized HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial MINNEAPOLIS, United States: HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic December 17, 2024 No Comments
Uncategorized Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial Darmstadt, Germany: Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% November 12, 2024 No Comments